Andrew Nixon
About Andrew Nixon
Andrew Nixon serves as the Manager of QC Materials and Cell Banks at Organogenesis, where he has worked since 2021. He has over two decades of experience in various roles within the company, demonstrating expertise in quality compliance and cell banking.
Work at Organogenesis
Andrew Nixon has been employed at Organogenesis since 2008, progressing through multiple roles over a span of more than a decade. He currently serves as the Manager of QC Materials and Cell Banks, a position he has held since 2021. Prior to this role, he was the QC Materials and Cell Bank Supervisor from 2017 to 2021. His earlier positions include Senior Cell Bank Specialist, Cell Bank Specialist IV, and Research Associate III in Cell Biology. His extensive experience at Organogenesis highlights his commitment to the organization and his expertise in quality control and cell banking.
Education and Expertise
Andrew Nixon earned a Bachelor of Science degree in Biology from Stonehill College, where he studied from 1996 to 2000. He completed his secondary education at Walpole High from 1992 to 1996. His educational background supports his extensive expertise in quality and compliance within the biotechnology sector, particularly in cell banking and adherence to FDA regulations.
Background
Andrew Nixon's career at Organogenesis began in 2008 as a Research Associate III in Cell Biology. Over the years, he has held various positions, including Manufacturing Associate I-II and Senior Product Development Associate. His roles have evolved, reflecting his growing responsibilities and expertise in the field. His long-standing tenure at Organogenesis demonstrates his dedication to the company and the biotechnology industry.
Achievements
Throughout his career at Organogenesis, Andrew Nixon has developed strong skills in cell banking and quality control. His progression from entry-level positions to managerial roles illustrates his professional growth and contributions to the organization. His knowledge of FDA regulations and compliance has been integral to his work, particularly in the areas of QC materials and cell banks.